These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 36204626)

  • 1. Gut microbiome and microbial metabolites in NAFLD and after bariatric surgery: Correlation and causality.
    Xia Y; Ren M; Yang J; Cai C; Cheng W; Zhou X; Lu D; Ji F
    Front Microbiol; 2022; 13():1003755. PubMed ID: 36204626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota and related metabolites in the pathogenesis of nonalcoholic steatohepatitis and its resolution after bariatric surgery.
    Martínez-Montoro JI; Kuchay MS; Balaguer-Román A; Martínez-Sánchez MA; Frutos MD; Fernández-García JC; Ramos-Molina B
    Obes Rev; 2022 Feb; 23(2):e13367. PubMed ID: 34729904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiome and Metabolites in Patients with NAFLD and after Bariatric Surgery: A Comprehensive Review.
    Hoozemans J; de Brauw M; Nieuwdorp M; Gerdes V
    Metabolites; 2021 May; 11(6):. PubMed ID: 34072995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
    Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial changes from bariatric surgery alters glucose-dependent insulinotropic polypeptide and prevents fatty liver disease.
    Dong TS; Katzka W; Yang JC; Chang C; Arias-Jayo N; Lagishetty V; Balioukova A; Chen Y; Dutson E; Li Z; Mayer EA; Pisegna JR; Sanmiguel C; Jacobs JP
    Gut Microbes; 2023; 15(1):2167170. PubMed ID: 36732495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota and Plasma Bile Acids Associated with Non-Alcoholic Fatty Liver Disease Resolution in Bariatric Surgery Patients.
    Pérez-Rubio Á; Soluyanova P; Moro E; Quintás G; Rienda I; Periañez MD; Painel A; Vizuete J; Pérez-Rojas J; Castell JV; Trullenque-Juan R; Pareja E; Jover R
    Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review.
    Głuszyńska P; Lemancewicz D; Dzięcioł JB; Razak Hady H
    J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Gut-Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC.
    Song Q; Zhang X
    Biomedicines; 2022 Feb; 10(3):. PubMed ID: 35327326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study.
    Wei L; Li M; Zeng N; Liu Y; Bai R; Zhang N; Song J; Zhang P; Yao Q; Yang Z; Zhao X; Zhang Y; Zhang P; Zhang Z
    BMC Surg; 2021 Jun; 21(1):298. PubMed ID: 34167531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota Dysbiosis in Human Obesity: Impact of Bariatric Surgery.
    Debédat J; Clément K; Aron-Wisnewsky J
    Curr Obes Rep; 2019 Sep; 8(3):229-242. PubMed ID: 31197613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term changes in the serum metabolome after laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass.
    Lee G; Park YS; Cho C; Lee H; Park J; Park DJ; Lee JH; Lee HJ; Ha TK; Kim YJ; Ryu SW; Han SM; Yoo MW; Park S; Han SU; Heo Y; Jung BH
    Metabolomics; 2021 Aug; 17(8):71. PubMed ID: 34355282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut-Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome.
    Pezzino S; Sofia M; Faletra G; Mazzone C; Litrico G; La Greca G; Latteri S
    Biology (Basel); 2022 Nov; 11(11):. PubMed ID: 36358323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score).
    von Schönfels W; Beckmann JH; Ahrens M; Hendricks A; Röcken C; Szymczak S; Hampe J; Schafmayer C
    Surg Obes Relat Dis; 2018 Oct; 14(10):1607-1616. PubMed ID: 30146425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.
    Nickel F; Tapking C; Benner L; Sollors J; Billeter AT; Kenngott HG; Bokhary L; Schmid M; von Frankenberg M; Fischer L; Mueller S; Müller-Stich BP
    Obes Surg; 2018 May; 28(5):1342-1350. PubMed ID: 29119336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota adaptation after weight loss by Roux-en-Y gastric bypass or sleeve gastrectomy bariatric surgeries.
    Sánchez-Alcoholado L; Gutiérrez-Repiso C; Gómez-Pérez AM; García-Fuentes E; Tinahones FJ; Moreno-Indias I
    Surg Obes Relat Dis; 2019 Nov; 15(11):1888-1895. PubMed ID: 31648978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma genistein after bariatric surgery could promote remission of NAFLD in patients with obesity.
    Wang G; Wang Y; Bai J; Li G; Liu Y; Deng S; Zhou R; Tao K; Xia Z
    Front Endocrinol (Lausanne); 2022; 13():1024769. PubMed ID: 36686492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A body weight loss- and health-promoting gut microbiota is established after bariatric surgery in individuals with severe obesity.
    Sanchez-Carrillo S; Ciordia S; Rojo D; Zubeldia-Varela E; Méndez-García C; Martínez-Martínez M; Barbas C; Ruiz-Ruiz S; Moya A; Garriga M; Salazar N; Botella-Carretero JI; Vega-Piñero B; de Los Reyes-Gavilán CG; Del Campo R; Ferrer M
    J Pharm Biomed Anal; 2021 Jan; 193():113747. PubMed ID: 33217711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease.
    Cherla DV; Rodriguez NA; Vangoitsenhoven R; Singh T; Mehta N; McCullough AJ; Brethauer SA; Schauer PR; Aminian A
    Surg Endosc; 2020 May; 34(5):2266-2272. PubMed ID: 31359195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut-Liver Axis.
    Cerreto M; Santopaolo F; Gasbarrini A; Pompili M; Ponziani FR
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is bariatric surgery resolving NAFLD via microbiota-mediated bile acid ratio reversal? A comprehensive review.
    Talavera-Urquijo E; Beisani M; Balibrea JM; Alverdy JC
    Surg Obes Relat Dis; 2020 Sep; 16(9):1361-1369. PubMed ID: 32336663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.